Lesson 1Infectious disease evaluation: latent infections (TB, CMV, EBV, VZV, HBV, HCV, HIV), vaccination review, prophylaxis planningDetails infectious disease evaluation in transplant candidates, emphasising latent infections, vaccination status, and individualised prophylaxis plans to minimise post‑transplant opportunistic infections and reactivation under immunosuppression.
Screening for TB, CMV, EBV, and VZVHBV, HCV, and HIV testing and stagingPre‑transplant vaccination catch‑up planDonor‑recipient serostatus risk matchingDesigning antiviral and PCP prophylaxisLesson 2Cardiology workup: noninvasive ischaemia testing, coronary angiography indications, functional capacity assessment, perioperative revascularisation criteriaCovers cardiology workup for transplant candidates, including noninvasive ischaemia testing, indications for coronary angiography, assessment of functional capacity, and criteria for revascularisation to reduce perioperative cardiac events.
Baseline ECG and echocardiographyStress testing and ischemia detectionIndications for coronary angiographyFunctional capacity and METs assessmentRevascularization versus medical therapyLesson 3Endocrine and metabolic optimisation: diabetes control strategies pre-transplant, obesity and nutritional optimisation, weight-loss options and timelineReviews endocrine and metabolic issues before kidney transplant, focusing on diabetes optimisation, obesity and nutrition, weight‑loss strategies, and realistic timelines to reach metabolic targets that reduce perioperative and long‑term complications.
Pre‑transplant HbA1c and glycemic targetsAdjusting insulin and non‑insulin therapiesObesity‑related surgical and graft risksNutritional assessment and protein‑energy statusPharmacologic and surgical weight‑loss optionsLesson 4Laboratory and imaging baseline tests: crossmatch/serology, HLA typing, PRA, baseline renal ultrasound and vascular imaging, baseline BK/JC viral statusOutlines essential laboratory and imaging tests that define the pre‑transplant baseline, including HLA typing, PRA, crossmatch, serologies, renal ultrasound, vascular imaging, and BK/JC viral status to guide donor selection and perioperative planning.
ABO typing, HLA typing, and PRA levelsComplement‑dependent and flow crossmatchBaseline renal ultrasound and DopplerCT or MR angiography of iliac vesselsBK and JC virus PCR and serologic statusLesson 5Decision criteria to accept or delay transplant: cardiopulmonary thresholds, infection control, vascular access/target vessel suitability, BMI and metabolic targetsExplains how multidisciplinary teams decide whether to proceed with or delay kidney transplant, integrating cardiopulmonary thresholds, infection control, vascular suitability, and BMI and metabolic goals to balance urgency against modifiable risk.
Cardiopulmonary fitness and VO2 thresholdsActive infection and sepsis exclusionTarget vessel imaging and suitabilityBMI cutoffs and weight‑loss milestonesMetabolic syndrome and blood pressure goalsLesson 6Pulmonary evaluation and anaesthesia risk: spirometry, sleep apnoea screening, frailty and functional status assessmentDescribes pulmonary and anaesthesia risk evaluation, including spirometry, sleep apnoea screening, frailty, and functional status, to estimate perioperative risk and guide optimisation, monitoring, and postoperative disposition planning.
History, exam, and spirometry indicationsChest imaging and pulmonary hypertensionScreening and management of sleep apneaFrailty indices and gait speed testingAnesthesia risk classification and planningLesson 7Vascular surgery assessment: peripheral arterial disease mapping, iliac/femoral vessel duplex/CT angiography, access site planningExplores vascular surgery assessment in kidney transplant planning, including mapping peripheral arterial disease, imaging iliac and femoral vessels, and selecting optimal access sites to ensure safe anastomosis and long‑term graft perfusion.
Clinical exam for peripheral arterial diseaseDuplex ultrasound of iliac and femoral vesselsCT angiography for complex vasculatureChoosing side and site for graft anastomosisManaging severe aortoiliac occlusive diseaseLesson 8Haematology and coagulation: platelet function, anticoagulation/antiplatelet management, transfusion thresholdsFocuses on haematologic and coagulation assessment, including anaemia, platelet function, and management of anticoagulant and antiplatelet agents, to define transfusion thresholds and minimise bleeding and thrombotic events around surgery.
Baseline CBC, iron studies, and anemia planPlatelet count, function, and uremic bleedingWarfarin, DOAC, and heparin bridgingAntiplatelet interruption and continuationRed cell and platelet transfusion thresholdsLesson 9Psychosocial and adherence assessment: evaluation of social support, substance use, medication adherence predictorsCovers structured psychosocial evaluation before transplant, including social support, mental health, substance use, and predictors of medication adherence, to identify barriers and design interventions that improve long‑term graft survival.
Standardized psychosocial screening toolsEvaluating caregiver and social supportScreening for depression and anxietySubstance use history and toxicology testsPredictors and remediation of nonadherenceLesson 10Comprehensive medical history and physical exam: diabetes, cardiovascular, peripheral vascular disease, dialysis access reviewSummarises the structure of a comprehensive pre‑transplant history and physical exam, emphasising cardiovascular, peripheral vascular, diabetes, and dialysis access review to identify contraindications and modifiable perioperative risks.
Structured transplant‑focused historyCardiovascular and peripheral vascular reviewDiabetes complications and foot examinationDialysis access function and infection historyMedication reconciliation and allergy review
